GIM
LRMR icon

Granahan Investment Management’s Larimar Therapeutics LRMR Stock Holding History

Granahan Investment Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17,751
Closed -$1.05M – 197
2018
Q4 		$1.05M Sell
17,751
-311
-2% -$30.7K 0.07% 164
2018
Q3 		$2.53M Buy
18,062
+12,258
+211% +$1.49M 0.14% 135
2018
Q2 		$712K Buy
5,804
+792
+16% +$67.3K 0.04% 187
2018
Q1 		$448K Buy
+5,012
New +$425K 0.03% 186
2016
Q3 		– Sell
-44,170
Closed -$3.17M – 237
2016
Q2 		$3.17M Buy
44,170
+13,918
+46% +$1.1M 0.12% 175
2016
Q1 		$2.42M Buy
30,252
+6,179
+26% +$488K 0.09% 189
2015
Q4 		$1.82M Sell
24,073
-6,178
-20% -$992K 0.06% 216
2015
Q3 		$11.6M Buy
30,251
+3,067
+11% +$1.38M 0.36% 102
2015
Q2 		$11.3M Sell
27,184
-127
-0.5% -$53.1K 0.32% 113
2015
Q1 		$13M Buy
27,311
+18,300
+203% +$8.69M 0.37% 99
2014
Q4 		$3.33M Buy
+9,011
New +$2.32M 0.1% 180

Other funds holding LRMR

AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Granahan Investment Management's LRMR Position: Q1 2019 in Review

Granahan Investment Management sold out of Larimar Therapeutics (LRMR) in Q1 2019, closing a stake of 17,751 shares — an estimated $1.05M sold.

Granahan Investment Management first reported a position in LRMR in Q4 2014 and held it in 11 quarters. The position peaked at $13M in Q1 2015. 85 funds tracked by Wall St. Rank hold LRMR as of Q1 2019.

  • Granahan Investment Management reported no remaining Larimar Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Granahan Investment Management sold 17,751 Larimar Therapeutics shares in Q1 2019, an estimated $1.05M.
  • Granahan Investment Management first reported a position in Larimar Therapeutics in Q4 2014 and held it in 11 quarters.
  • Granahan Investment Management's Larimar Therapeutics position peaked at $13M in Q1 2015.
  • 85 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2019.

Based on Granahan Investment Management's 13F filing for Q1 2019, filed 14 May 2019.